RespireRx Pharmaceuticals Inc.

Qualified
CIK: 849636•DE•Tier2

Equity (common or preferred stock) · Audited · Healthcare · SIC 2834

$7.5M
Qualified
maximum offering price, as qualified
—
Reported Sold
no 1-K or 1-Z states a sold amount
4
Filings
across 1 offering

Equity Classes

TypeClassOutstandingCUSIPPublicly Traded
common(as of 11/10/21)94,907,943761227305OTC Markets
debt(as of 11/08/21) mat val + int2,259,138——
preferred(as of 09/30/21 and 12/31/20)37,500——

Service Providers

RoleProviderCRD
auditorHaskell & White (non-audit)—
blue skyFaegre Drinker Biddle & Reath LLP—
finderNone—
legalFaegre Drinker Biddle & Reath LLP; Placement Agent legal—
promoterNone—
sales commissionPrimary Capital LLC—
underwriterNone127921

Offerings

File NumberFilingsFirst FiledLast FiledQualifiedPrice/SecuritySecurities OfferedOutstandingAggregate OfferingEstimated NetSupplementsLast SupplementCRD
024-1160232021-08-092021-12-012021-12-13$0.02375,000,00094,907,943$7.5M$6.8M72022-03-08127921
Embarc dashboard

Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.

  • Every caption as the filer wrote it, across every annual report — not just the latest 1-K
  • Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
  • A sparkline on each annual-statement line, so the shape is visible before the figures
  • A revenue series dated to the filings that reported it
  • A filing history that says what each document contributed, not only that it exists
  • Follow it, and see it change on your watchlist
Open in the dashboard
External link: SEC Filings